Otsuka Pharmaceutical Co., Ltd. (OPC) conducts its business operations with the aim of contributing to better health for people worldwide under its corporate philosophy of “Otsuka - people creating new products for better health worldwide.” Based on the two main businesses of pharmaceuticals that help treat illness and Nutraceuticals Products that contribute to day-to-day wellness, OPC is engaged in the research and development, manufacture, and sale of innovative, creative products. Seeking to cultivate an ethic and vitality appropriate to an enterprise involved with human health, OPC strives to build a symbiotic relationship with local communities and the natural environment while aiming to be a global value-creating company.

Focusing on solving medical care issues such as the curing of disease and the improvement of quality of life (QOL), OPC aims to develop original pharmaceutical products in the top priority areas of the central nervous system and oncology and in the priority areas of cardiovascular, digestive, and respiratory systems, infectious disease, and ophthalmology and dermatology. At present, the company is moving forward with the development of new drugs in the fields of tuberculosis, epilepsy, and rheumatism.
In Japan, OPC markets the antipsychotic Abilify and bronchodilator Meptin in addition to such flagship products as the anti-gastritis and anti-gastric ulcer agent Mucosta and the antiplatelet agent Pletaal. In the field of ophthalmology the company offers Mikelan Ophthalmic Solution for treatment of glaucoma and intraocular hypertension. In the dermatology field the company markets the new quinolone antibacterial agent Acuatim. These products, together with the products in its I.V. solutions business, are aiding the treatment of disease.
OPC’s diagnostics business develops diagnostic agents for in vivo and in vitro use, as well as reagents for research. The company’s rapid test for the detection of influenza A and B viral antigens, which is an in vitro diagnostic product in the field of infectious disease, delivers quick and accurate diagnostic results thanks to its high detection sensitivity and short reaction time.

OPC’s Nutraceuticals Products business develops products based on the scientific rationale of nutraceuticals. It provides these products to consumers together with information about the basic concept and everyday situations in which the products’ distinctive features excel. Pocari Sweat, Calorie Mate, Oronamin-C Drink and other original products that promote day-to-day wellness have created new markets and are popular among numerous consumers as time-honored best-sellers.
In recent years, OPC has been making a push to make this business more international in cooperation with group companies around the world.
SOYJOY has been launched in Asia and the U.S. as a global brand, and Pocari Sweat is also expanding globally, especially in Asia, leveraging the concept of electrolyte replacement.
In the skincare field, OPC’s research focuses on health that starts with your skin, and its original concept of cosmedics is driving the growth of its InnerSignal and UL・OS brands.
OPC strives to develop products based on scientific rationale and a global perspective, carries out creative, innovative marketing, and provides products with reliable quality as it aspires to contribute to the health of consumers worldwide as a leading wellness company.